Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Dacomitinib
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Dacomitinib Vizimpro
®
(15mg, 30mg and 45mg film-coated tablets)
Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Dacomitinib
Dacomitinib [Specialist Drug]
Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Links found
TA595 Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer